BackPharvaris NV Overview
Pharvaris NV

Pharvaris NV Target Price

See Pharvaris NV's analyst price targets ($54) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$33.87

Average Target Price

$54.2560.2% upside

4 analysts in the last 4 months

High: $74 | Low: $42

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-15Wells FargoYanan Zhu$5562.4% upsideOpen
2026-06-25Morgan StanleyMaxwell Skor$4635.8% upsideOpen
2026-05-13UBS$74118.5% upsideOpen
2026-04-08Wolfe Research$4224% upsideOpen
2026-03-09RBC Capital$5253.5% upsideOpen
2025-12-04Morgan StanleyMaxwell Skor$4121.1% upsideOpen
2025-12-04Oppenheimer$5047.6% upsideOpen
2025-12-04GuggenheimDebjit Chattopadhyay$3915.1% upsideOpen
2025-12-03Leerink Partners$3812.2% upsideOpen
2025-10-15H.C. Wainwright$6077.1% upsideOpen
2024-10-14OppenheimerJustin Kim$4224% upsideOpen
2024-04-11JMP SecuritiesJonathan Wolleben$5047.6% upsideOpen
2023-09-25WedbushLaura Chico$2720.3% downsideOpen
2023-01-11JMP Securities$2332.1% downsideOpen
2022-12-09JMP Securities$2235% downsideOpen

Pharvaris NV (PHVS) FAQ

Pharvaris NV posts a target price of $54. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $54 for PHVS means covering analysts, on average, see the stock 60.2% upside of $33.87 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for PHVS's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Pharvaris NV's other metric pages and overview cover the third.

Judging Pharvaris NV against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $54 here, then scan peer and history charts to see if the gap is persistent.